Pricing Log in Create free account

Phio Pharmaceuticals Corp. (PHIO) vs Palatin Technologies, Inc. (PTN)

Phio Pharmaceuticals Corp. and Palatin Technologies, Inc. are both Biotechnology companies. Phio Pharmaceuticals Corp. and Palatin Technologies, Inc. are of similar size ($11.6M and $10.8M). Palatin Technologies, Inc. grew revenue faster over the last twelve months: 110.9% against 79.0%. Phio Pharmaceuticals Corp. has the higher net margin (0.00% vs −63.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Phio Pharmaceuticals Corp. leads on 8 and Palatin Technologies, Inc. on 8.

Valuation

Metric PHIO PTN Biotechnology median
P/E n/m n/m 8.50
P/S 74.31 1.29 9.71
P/B 0.80 2.55 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.20 n/m 0.64
EV/Sales (19.55) 0.73 9.21
Earnings yield (148.28%) (49.33%) (33.15%)
Free cash flow yield (120.77%) (79.85%) (25.50%)

Profitability

Metric PHIO PTN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (65.74%) 0.00%
Net margin 0.00% (63.54%) 0.00%
Free cash flow margin 0.00% (103.07%) 0.00%
Return on equity (113.71%) (877.60%) (56.36%)
Return on assets (100.78%) (142.11%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PHIO PTN Biotechnology median
Revenue growth (TTM) 78.95% 110.89% 6.02%
EPS growth (last fiscal year) 84.03% 90.79% 30.26%
Revenue growth, 5-year CAGR (21.62%) 156.83% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PHIO PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.39 4.61 4.72
Net debt to EBITDA 2.28 0.87 0.96

Dividend

Metric PHIO PTN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PHIO PTN Biotechnology median
Market cap 10.75m 11.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack